Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
1. The selectivity of eight chemical inhibitors has been extensively evaluated with 10 cDNA-expressed human cytochrome P450 isoforms (CYP). The results indicate that sulphaphenazole, quinidine and alpha-naphthoflavone are selective inhibitors of CYP2C9 (IC50 = 0.5-0.7 microM), CYP2D6 (0.3-0.4 microM) and CYP1A (0.05-5 microM) respectively on the basis of the IC50, which are much lower than those of other P450 isoforms (> 10-fold). 2. Ketoconazole exhibited potent inhibition of both CYP3A4-catalysed metabolism of phenanthrene, testosterone, diazepam (IC50 = 0.03-0.5 microM) and CYP1A1-catalysed deethylation of 7-ethoxycoumarin (0.33 microM). The selectivity of ketoconazole for other P450s was highly related to the concentration used. 3. Diethyldithiocarbamate, orphenadrine and furafylline were shown separately to be less selective inhibitors of CYP2E1, CYP2B6 and CYP1A isoforms by a broad range of IC50 that overlap those observed with other P450 isoforms. 4. Furafylline, quinidine and alpha-naphthoflavone activated CYP3A4-catalysed phenanthrene metabolism by 1.7-, 2- and 15-fold respectively. 5. The selectivity of orphenadrine and ketoconazole was further examined by using inhibitory monoclonal antibodies (MAb). Inhibitory MAb specific for the individual P450 isoforms may be of greater value than chemical inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All positive controls were found to show potent CYP450 inhibition and the IC50 values were consistent with previously reported values [22,23,24].”
From Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents (2014) · cites this paper as [22]
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Drug Metabolism and Disposition
(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,515
Protein Determination of Large Numbers of Samples
Miller, G. L. (1959) · Analytical Chemistry · doi:10.1021/ac60149a611 · Cited by 1,585
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
Guengerich, F. P., Kim, D. H., & Iwasaki, M. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00020a008 · Cited by 1,169
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
Chang, T. K. H., Weber, G. F., Crespi, C. L., & Waxman, D. J. (1993) · PubMed · Cited by 545
Yamazaki, H., Inui, Y., Yun, C.-H., Guengerich, F. P., & Shimada, T. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1789 · Cited by 398
(1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00268-8 · Cited by 369
Bourrié, M., Meunier, V, Berger, Y., & Fabre, G. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12826-7 · Cited by 363
Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Korzekwa, K. R. (1994) · Biochemistry · doi:10.1021/bi00187a009 · Cited by 351
Self-citationChang, T. K. H., Gonzalez, F. J., & Waxman, D. J. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1259 · Cited by 251
Self-citationKharasch, E. D., & Thummel, K. E. (1993) · Anesthesiology · doi:10.1097/00000542-199310000-00023 · Cited by 232 · cited 1×
“…identi cation of individual P450 isoforms (Johnson et al. 1979, Tyndale et al. 1991, Smith and Jones 1992, Yun et al. 1992, Chang et al. 1993, 1994, Kharasch and Thummel 1993, Kunze and Trager 1993, * Author for correspondence; e-mail : magangj shou! merck.com Xenobiotica ISSN 0049-8254 print }…”
BackgroundIsoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline
Kunze, K. L., & Trager, W. F. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00035a009 · Cited by 216
Selective Inhibitors of Cytochromes P450
Halpert, J. R., Guengerich, F. P., Bend, J. R., & Correia, M. A. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1061 · Cited by 214 · cited 1×
“…include the use of speci c chemical inhibitors and inhibitory monoclonal antibodies (MAb) to individual P450 isoforms (Gelboin et al. 1993, Halpert et al. 1994), studies with individual cDNA-expressed P450 enzymes (Gonzalez and Korzekwa 1995), and metabolic correlation of a given…”
BackgroundPurification and characterization of six cytochrome P-450 isozymes from human liver microsomes
Wang, P. P., Beaune, P., Kaminsky, L. S., Dannan, G. A., Kadlubar, F. F., Larrey, D., & Guengerich, F. P. (1983) · Biochemistry · doi:10.1021/bi00292a019 · Cited by 190 · cited 1×
“Microsomes were prepared as described by Wang et al. (1983)and were reconstituted in a bu å er (pH 7.4) containing 0.25 m sucrose, 1 m m EDTA, 0.5 mm DTT, 1.15% KCl and 0.1 m KPi.”
MethodInfluentialOtton, S. V., Inaba, T., & Kalow, W. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90332-1 · Cited by 186
Cytochromes P450 Expression Systems
Gonzalez, F. J., & Korzekwa, K. R. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002101 · Cited by 173 · cited 1×
“…antibodies (MAb) to individual P450 isoforms (Gelboin et al. 1993, Halpert et al. 1994), studies with individual cDNA-expressed P450 enzymes (Gonzalez and Korzekwa 1995), and metabolic correlation of a given candidate with a diagnostic substrate as well as an association between the…”
BackgroundSelf-citationTyndale, R. F., KALOW, W., & Inaba, T. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05588.x · Cited by 118
Back, D., Tjia, J., Karbwang, J., & Colbert, J. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03359.x · Cited by 112
Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn, H., White, R. B., & Stevens, J. C. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07488-4 · Cited by 111
Roles of human liver cytochrome P4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene.
Yun, C., Shimada, T., & Guengerich, F. P. (1992) · PubMed · Cited by 107
Lang, D. H., Rettie, A. E., & Böcker, R. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970081l · Cited by 90 · cited 1×
“…} ISSN 1366-5928 online ’ 2000 Taylor & Francis Ltd http: } } www.tandf.co.uk} journals Hasegawa et al. 1994, Baldwin et al. 1995,Newton et al. 1995, Bonnabry et al. 1996, Bourrie et al. 1996, Spracklin et al. 1996, Lakshmi et al. 1997, Lang et al. 1997, Sanderink et al. 1997, Stevens et al. 1997).”
BackgroundInvolvement of Human CYP1A Isoenzymes in the Metabolism and Drug Interactions of Riluzole In Vitro
Sanderink, G.-J., Bournique, B., Stevens, J., Petry, M., & Martinet, M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36944-7 · Cited by 80
[8] Expression of mammalian cytochrome P450 using vaccinia virus
Gonzalez, F. J., Aoyama, T., & Gelboin, H. V. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)06079-i · Cited by 73 · cited 1×
“Preparation of baculovirus- and vaccinia virus-expressed P450s cDNAs encoding for individual cytochrome P450 isoforms were constructed into vaccinia (Battula et al. 1987, Gonzalez et al. 1991a) and baculovirus vectors (Gonzalez et al. 1991b).”
MethodSelf-citationShou, M., Korzekwa, K. R., Krausz, K. W., Crespi, C. L., Gonzalez, F. J., & Gelboin, H. V. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90334-4 · Cited by 72
Self-citationBattula, N., Sagara, J., & Gelboin, H. V. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4073 · Cited by 67
Self-citationHuman reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin, D. K., Thummel, K. E., & Kharasch, E. D. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07492-6 · Cited by 64
[9] Expression of mammalian cytochrome P450 using baculovirus
Gonzalez, F. J., Kimura, S., Tamura, S., & Gelboin, H. V. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)06080-m · Cited by 61 · cited 1×
“Preparation of baculovirus- and vaccinia virus-expressed P450s cDNAs encoding for individual cytochrome P450 isoforms were constructed into vaccinia (Battula et al. 1987, Gonzalez et al. 1991a) and baculovirus vectors (Gonzalez et al. 1991b).”
MethodSelf-citationRole of human liver microsomal CYP2C9 in the biotransformation of lornoxicam
Bonnabry, P., Leemann, T., & Dayer, P. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/bf00226332 · Cited by 61
Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4
Gelboin, H. V., Krausz, K. W., Goldfarb, I. S., Buters, J., Yang, S. K., Gonzalez, F. J., Korzekwa, K. R., & Shou, M. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02077-2 · Cited by 53
Self-citationHuman Liver CYP2B6-Catalyzed Hydroxylation of RP 73401
Stevens, J. C., White, R. B., Hsu, S. H., & Martinet, M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36941-1 · Cited by 48
Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Lakshmi, V. M., Zenser, T. V., & Davis, B. B. (1997) · PubMed · Cited by 32
Metabolism of gestodene in human liver cytosol and microsomes in vitro
Ward, S. A., & Back, D. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90299-c · Cited by 21
Research works printed but not linked: 11
- BOURRIE M., 1996, Journal of Pharmacology and Experimental Therapeutics, 277, 321
- CHANG T. K., 1993, Cancer Research, 53, 5629
- GELBOIN H. V, 1993, Pharmacological Review, 45, 413
- HASEGAWA T., 1994, D rug Metabolism and Disposition, 22, 916
- HEYN H., 1996, Drug Metabolism and Disposition, 24, 948
- NEWTON D. J., 1995, Drug Metabolism and Disposition, 23, 154
- SAI Y., 1999, Pharmacogentics, 9, 229
- SANDERINK G. J., 1997, Journal of Pharmacology and Experimental Therapeutics, 282, 1465
- SPRACKLIN D. K., 1996, Drug Metabolism and Disposition, 24, 976
- STEVENS J. C., 1997, Journal of Pharmacology and Experimental Therapeutics, 282, 1389
- YUN C. H., 1992, Cancer Research, 52, 1868
Cited by
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Roman, R. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00021.2001 · Cited by 1,309
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
“[135] Although in one study 10 μmol/L quinidine, which is a strong CYP2D6 inhibitor,[163] was found to inhibit methadone N-demethylation in human liver microsomes by up to 25%,[135] two other studies did not find a significant inhibition of this metabolic pathway by quinidine.”
ResultCytochrome P450 ω-Hydroxylase Pathway of Tocopherol Catabolism
Sontag, T. J., & Parker, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201466200 · Cited by 458
Fleming, I., Michaelis, U. R., Bredenkötter, D., Fisslthaler, B., Dehghani, F., Brandes, R. P., & Busse, R. (2001) · Circulation Research · doi:10.1161/01.res.88.1.44 · Cited by 440
Metadata
- Authors
- Sai, Y., Dai, R., Yang, T. J., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., & Shou, M.
- Affiliations
- National Institutes of Health (US)
- Venue
- Xenobiotica
- Publisher
- Informa UK Limited
- Published
- 2000-01
- Volume
- 30
- Issue
- 4
- Pages
- 327-343
- ISSN
- 0049-8254 (ISSN-L)
- 1366-5928
- OpenAlex
- W2043368734
- Cited by
- 138
- References
- 35
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 5
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Xenobiotica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- cytochrome P450 inhibitors, inhibitor selectivity, ketoconazole, quinidine, alpha-naphthoflavone, diethyldithiocarbamate, orphenadrine, furafylline, CYP3A4, CYP2C9, CYP2D6, CYP1A, CYP2E1, CYP2B6, testosterone metabolism, diazepam metabolism, enzyme induction
- MeSH terms
- Enzyme Inhibitors, Humans, Isoenzymes, Substrate Specificity, DNA, Complementary, Cytochrome P-450 Enzyme Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.